CLDX Celldex Therapeutics Inc

Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

$29.83  +1.64 (5.82%)
As of 03/02/2021 15:59:53 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
02/12/2001
39,567,065
617,520
$1,115,395,562
0.00%
SEC Edgar Online
10-Q
10-K
15117B202
US15117B2025
BJLV8T9

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-23.08
4.85
246.82
-21.01%
-1,069.42%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy